Business Context and Reporting Period
This Form 6-K filing by Universe Pharmaceuticals INC (Nasdaq: UPC) covers the month of December 2021. The report discloses a change in the Company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a disclosure of a corporate governance event rather than a financial performance report.
Material Changes
- Change of Auditor: On December 7, 2021, the Company appointed YCM CPA INC ("YCM") as its new independent registered public accounting firm, effective immediately.
- Dismissal of Prior Auditor: Friedman LLP ("Friedman") was dismissed on December 1, 2021.
- Reason for Change: The Company states the decision was not the result of any disagreement with Friedman regarding accounting principles, financial statement disclosure, or auditing scope.
- Prior Audit Opinion: Friedman's audit reports for the fiscal years ended September 30, 2019, and 2020 did not contain adverse opinions, disclaimers, or qualifications.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future operations. No specific risks or contingencies were disclosed other than the standard procedural disclosure regarding the auditor change. The Company confirmed that no consultations occurred with YCM regarding accounting principles or audit opinions during the two most recent fiscal years prior to the engagement.
Investor Verification Checklist
- Verify the independence and qualifications of the new auditor, YCM CPA INC.
- Review the letter from Friedman LLP (Exhibit 99.1) to confirm their agreement with the Company's statement regarding the lack of disagreement.
- Monitor future filings for any restatements or changes in accounting practices following the auditor transition.
- Check for any subsequent filings that might reveal underlying reasons for the auditor change not explicitly detailed in this summary.